Sunday, August 14, 2005


Images Courtesy of

This country is in trouble. We are losing our best potential and our brightest future to the drug Methamphetamine. Today, it is becoming an epidemic in America; with a significant increase of 71 percent between the first half of 1996 and the second half of 1996 (from 4,000 to 6,800). Take note:
Methamphetamine (also known as Speed, Meth, Crystal, Crank, Ice, etc.) is instantly addictive.

Meth is distributed at club and party venues like candy, creating hundreds of new victims a week.

Once the habit has been established, it is almost impossible to break.

Meth labs can be found on any suburban street, apartment, farm, motel or hotel; creating severe environmental problems in those areas.

Meth ingredients may include battery acid, anti-freeze, lye, acetone, lighter fluid and drain cleaner.

Meth labs may give off an odor similar to cat urine or ammonia.

Children from homes containing meth labs are now considered child abuse victims because of the toxic danger of Meth.

Your co-worker may be an addict.

Your boss may be an addict.

Your doctor may be an addict.

Your teen daughter may be an addict.

Your postman may be an crosses all racial and socio-economical barriers.

Meth SHRINKS the brain.

Meth rots and breaks off teeth.

Meth ages and scars the skin.

Meth causes seizures and brain damage.

Meth is lethal.
The images above are from the website Oregon, which has a post entitled Faces of Meth. This site features mugshots of people at the beginning of meth usage and once again when they are deep into the addiction.

You'll be shocked at the visual changes Meth creates in its victims.
View the images here.

For resources and information about Methamphetamine, visit the links below:

InfoFacts - Methamphetamine

National Clearinghouse for Alcohol and Drug Information at 800-729-6686.

White House Office of National Drug Control Policy


Medical Effects of Methamphetamine on Children

Addictive Effects of HIV and Chronic Methamphetamine Use

The Effects of Methamphetamine on the Brain


moi said...

Ok. This post just scared the s*** out of me. I live in the "meth capital of the United States," according to Parade magazine, and other resources. Every week another meth "lab" is discovered, and it's always someone's home, and there are usually children taken from the home, and they are very often in nice neighborhoods. I see people with faces like these every day, all over the place. I see faces like these at work, at the mall, in restaurants.

Thank you, thank you, thank you for showing the rest of the world what The Faces of Meth look like.

iccq8ezhk60twfr said...

Stock For Your Review - FCPG

Current Profile
Faceprint Global Solutions (FCPG)
Current Price $0.15

A U.S. based-company dedicated to the goal of
bringing effective security solutions to the marketplace.

With violent and white-collar terrorism on the rise,
companies are starving for innovative security solutions.

FCPG is set to bring hot new security solutions to
the industry, with currently over 40 governmental and
non-governmental contracts, being negotiated.

Please Review Exactly What this Company Does.

Why consider Faceprint Global Solutions (FCPG)?

Faceprint Global Solutions (FCPG) holds the exclusive
marketing rights from Keyvelop, to sell the world�s
leading encryption technology to be distributed directly
to the Healthcare industry in North America.

Faceprint Global Solutions has completed its biometric
software that recognizes facial features of individuals
entering and leaving through airports, ship yards, banks,
large buildings, etc.

FCPG acquired Montreal-based Apometrix Technologies,
which enhances the companies mission of being a
full-service provider to the multi-application smart
card industry. The North American market appears ready
for significant expansion of price-competitive, proven,
multi-application solutions on smart cards. Apometrix's
forecast of over 300 customers and sales of more than $50
million in North America over the next five years, appears
very realistic, according to company management.

Faceprint Global Solutions is currently in contract negotiations
with over 40 governmental agencies and businesses seeking to use
their encryption, biometric, and smart-card technologies.

Breaking News for Faceprint Global Solutions (FCPG)

Faceprint Global Solutions (FCPG) is pleased to announce that
IBM will now offer the world�s leading encryption software to
its major Healthcare clients in North America.

With FCPG owning the exclusive North American rights to distribute
the worlds leading encryption and transmission software developed by
Keyvelop, FCPG is poised to capture large volumes of sales generated
by customers currently using IBM�s software in the healthcare and other

�This is a very positive move for FCPG and for Keyvelop,� said FCPG
CEO Pierre Cote. �We are very happy about the decision to go with IBM.
This is a continuation of the progress made by everyone associated
with FCPG and its partners.�

Buell Duncan, IBM's general manager of ISV & Developer Relations commented,
�Collaborating with Keyvelop will ensure that we develop open solutions that
are easy to maintain and cost effective for our customers in the healthcare
and life sciences industry.�

Among other things, this new software technology which is currently
being used by a number of European healthcare companies, is used to
send any file, regardless of format or size. Encryption keys, evidence
of transmission integrity with fingerprint calculation, time-stamping
of all actions and status record updating, pre-checking sender and
receiver identities, validating file opening dates are part of Keyvelop features.

About FacePrint Global Solutions, Inc.

FCPG operates a business, which develops and delivers a variety of
technology solutions, including biometric software applications on
smart cards and other support mediums (apometric solutions). FCPG�s
products provide biometric solutions for identity authentication and a
host of smart card- and biometrics-related hardware peripherals and
software applications. Apometrix, FCPG�s wholly-owned subsidiary,
combines on-card or in-chip multi-application management solutions
with best-of-breed �in-card matching� biometrics. Keyvelop�s secure
digital envelope solution and Apometrix�s on-card biometrics work
together to produce the winning combination in the fields of security,
traceability and identity management.


The examples above show the Awesome, Earning Potential of little known
Companies That Explode onto Investor�s Radar Screens. This sto,ck will
not be a Secret for long. Then You May Feel the Desire to Act Right Now!
And Please Watch This One Trade!


Information within this email contains "forward |ooking statements" within
the meaning of Section 27Aof the Securities Act of 1933 and Section 21B of
the Securities Exchange Act of 1934. Any statements that express or involve
discussions with respect to predictions, expectations, beliefs, plans,
projections, objectives, goals, assumptions or future events or performance
are not statements of historical fact and may be "forward |ooking statements".
"Forward |ooking statements" are based on expectations, estimates and projections
at the time the statements are made that involve a number of risks and uncertainties
which could cause actual results or events to differ materially from those presently
anticipated. We were paid a sum of three thousand USD to disseminate this information
from ir marketing. Forward loking statements in this action may be identified through
the use of words such as "projects", "foresee", "expects", "will", "anticipates",
"estimates", "believes", "understands" or that by statements indicating
certain actions "may", "could", or "might" occur. Risk factors include
general economic and business conditions, the ability to acquire and develop
specific projects, the ability to fund operations and changes in consumer and
business consumption habits and other factors over which the company has little
or no control. The publisher of this newsletter does not represent that the
information contained herein are true and correct.